ViAqua Therapeutics
Developing an orally administered particle-based platform for the delivery of rna to improve resistance against diseases that attack shrimp and other aquaculture species. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€30—45m (Dealroom.co estimates Sep 2023.)
Company register number 515130250
Haifa Haifa District (HQ)
Authorizing premium user...